🌐 Global Live
S&P 500$7,675.7-0.02%NASDAQ Composite$26,130.2-0.08%Dow Jones Industrial Average$53,463.88-0.21%FTSE 100$10,841.02-0.34%Nikkei 225$66,131.98-0.20%HANG SENG INDEX$25,565.74+0.21%EUR/USD$1.1646-0.10%GBP/USD$1.3579-0.11%USD/JPY$159.43+0.11%USD/INR₹95.53+0.13%Gold Dec 26$4,650.6-0.06%Silver Sep 26$69.09+0.39%Crude Oil Oct 26$82.48+0.30%NIFTY 50₹24,090.85-1.00%S&P BSE SENSEX₹76,933.59-0.93%S&P 500$7,675.7-0.02%NASDAQ Composite$26,130.2-0.08%Dow Jones Industrial Average$53,463.88-0.21%FTSE 100$10,841.02-0.34%Nikkei 225$66,131.98-0.20%HANG SENG INDEX$25,565.74+0.21%EUR/USD$1.1646-0.10%GBP/USD$1.3579-0.11%USD/JPY$159.43+0.11%USD/INR₹95.53+0.13%Gold Dec 26$4,650.6-0.06%Silver Sep 26$69.09+0.39%Crude Oil Oct 26$82.48+0.30%NIFTY 50₹24,090.85-1.00%S&P BSE SENSEX₹76,933.59-0.93%
MoneyPlant Logo
MoneyPlant
LIVE
Home/Indices/Nifty Pharma

Nifty Pharma

LIVE
NSEIndia^CNXPHARMA
26,848.75
+284.75(+1.07%)

Market Summary

Previous Close
26,564
Open
Day Range
26,607.95 - 26,856.05
52-Week Low
21,149.9
52-Week High
26,856.05
Exchange
NSE India

Top Constituents

Showing top 20 by weightage/val
#SymbolCompanyPrice ()Change% ChangeMarket CapVolume
1SUNPHARMASUN PHARMACEUTICAL IND L1,913.3 13.80+0.73%11.07 L
2DRREDDYDR. REDDY S LABORATORIES1,177 5.00-0.42%10.44 L
3CIPLACIPLA LTD1,420 17.30+1.23%5.33 L
4DIVISLABDIVI S LABORATORIES LTD9,060 35.00+0.39%5.27 L
5BIOCONBIOCON LIMITED.418.4 0.90+0.22%17.13 L
6AUROPHARMAAUROBINDO PHARMA LTD1,637 14.00+0.86%7.17 L
7LUPINLUPIN LIMITED2,158.1 26.90-1.23%9.64 L
8GLENMARKGLENMARK PHARMACEUTICALS2,460 21.70+0.89%4.47 L
9TORNTPHARMTORRENT PHARMACEUTICALS L4,999 109.00+2.23%3.18 L
10ALKEMALKEM LABORATORIES LTD.5,320 16.50+0.31%1.67 L

Index Overview

The Nifty Pharma is a benchmark index that represents the performance of top Indian companies listed on the NSE. It is widely used by investors and fund managers as a primary gauge of the Indian equity market's health and direction.

Primary Sectors: Banking, IT, Energy, FMCG, and Metals.

Market Outlook

Stay updated with the latest market trends and expert analysis on Nifty Pharma.

View News Hub